CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Deferred Compensation, Share-Based Payments [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 284	$ 45,264	$ 76,974	$ (774)	$ 3,004	$ 124,752
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	5,686,584
Net income for period			12,332			12,332
Other comprehensive loss, net of tax					(1,700)	(1,700)
Common stock dividends declared			(2,566)			(2,566)
Stock based compensation-restricted stock awards		235		449		684
Stock options exercised	$ 1	30				31
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	3,510
Issuance of restricted common stock	$ 1	623		(624)
[custom:StockIssuedDuringPeriodSharesRestrictedCommonStock]	27,700
Issuance of director’s restricted stock awards		126		(126)
[custom:StockIssuedDuringPeriodSharesDirectorsRestrictedStockAwards]	5,600
Ending balance, value at Sep. 30, 2021	$ 286	46,278	86,740	(1,075)	1,304	133,533
Shares, Outstanding, Ending Balance at Sep. 30, 2021	5,723,394
Beginning balance, value at Jun. 30, 2021	$ 286	46,217	84,174	(1,224)	2,256	131,709
Shares, Outstanding, Beginning Balance at Jun. 30, 2021	5,723,394
Net income for period			3,453			3,453
Other comprehensive loss, net of tax					(952)	(952)
Common stock dividends declared			(887)			(887)
Stock based compensation-restricted stock awards		61		149		210
Ending balance, value at Sep. 30, 2021	$ 286	46,278	86,740	(1,075)	1,304	133,533
Shares, Outstanding, Ending Balance at Sep. 30, 2021	5,723,394
Beginning balance, value at Dec. 31, 2021	$ 286	46,374	89,995	(925)	870	136,600
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	5,723,394
Net income for period			11,750			11,750
Other comprehensive loss, net of tax					(23,191)	(23,191)
Common stock dividends declared			(2,765)			(2,765)
Stock based compensation-restricted stock awards		240		615		855
Stock options exercised	$ 1	94				95
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	11,070
Issuance of director’s restricted stock awards		205		(205)
[custom:StockIssuedDuringPeriodSharesDirectorsRestrictedStockAwards]	7,980
Issuance of restricted stock awards	$ 2	811		(813)
Stock Issued During Period, Shares, Restricted Stock Award, Gross	28,700
Issuance of performance based stock awards		(183)				(183)
[custom:StockIssuedDuringPeriodSharesPerformanceBasedStockAwards]	12,822
Transfer due to 2-for-1 forward stock split	$ 289	(289)
Ending balance, value at Sep. 30, 2022	$ 578	47,252	98,980	(1,328)	(22,321)	123,161
Shares, Outstanding, Ending Balance at Sep. 30, 2022	5,783,966
Beginning balance, value at Jun. 30, 2022	$ 578	47,205	95,568	(1,512)	(14,536)	127,303
Shares, Outstanding, Beginning Balance at Jun. 30, 2022	5,783,966
Net income for period			4,336			4,336
Other comprehensive loss, net of tax					(7,785)	(7,785)
Common stock dividends declared			(924)			(924)
Stock based compensation-restricted stock awards		47		184		231
Ending balance, value at Sep. 30, 2022	$ 578	$ 47,252	$ 98,980	$ (1,328)	$ (22,321)	$ 123,161
Shares, Outstanding, Ending Balance at Sep. 30, 2022	5,783,966